Hormone Replacement Therapy Versus the Combined Oral Contraceptive Pill in Premature Ovarian Failure: A Randomized Controlled Trial of the Effects on Bone Mineral Density | Zendy

Beth Cartwright | Zendy; J. Robinson | Zendy; Paul T. Seed | Zendy; Ignac Fogelman | Zendy; Janice Rymer | Zendy

Open Access

Hormone Replacement Therapy Versus the Combined Oral Contraceptive Pill in Premature Ovarian Failure: A Randomized Controlled Trial of the Effects on Bone Mineral Density

Author(s) -

Beth Cartwright,

J. Robinson,

Paul T. Seed,

Ignac Fogelman,

Janice Rymer

Publication year - 2016

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2015-4063

Subject(s) - bone mineral , medicine , hormone replacement therapy (female to male) , femoral neck , bone density , randomized controlled trial , bone remodeling , premature ovarian failure , estrogen , osteoporosis , testosterone (patch)

Women with premature ovarian failure (POF) face many years of estrogen deficiency. One of the major consequences is bone loss. The optimal form of estrogen replacement is unknown and management is not evidence based. The 2 broad options are combined hormone replacement therapy (HRT) or the combined oral contraceptive pill (COCP).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research